Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Pet Cancer Therapeutics Market
Pet Cancer Therapeutics Market size registered a valuation of over USD 369 billion in 2022 and is slated to exhibit more than 10% CAGR from 2023 to 2032 driven by the increasing willingness of pet parents to spend on their pets’ healthcare.
The industry need is primarily fueled by a swelling number of pet cancer cases. The upsurge in canine & feline cancer is primed to drive the demand for effective pet cancer therapeutics to manage cancer conditions, further driving the business progress. According to the Merck Veterinary Manual, genetic factors can contribute to the development of cancer in companion animals. Additionally, positive efforts to improve canine therapies such as government funding have uplifted the industry outlook.
Furthermore, significant awareness among pet owners concerning pet diseases is expected to stimulate industry expansion. The growing understanding of pet cancer and commercially available treatments is boosting the demand for therapeutics and has broadened the use of these products. The prevalence of smartphones and the information available online have greatly increased pet owners' understanding of various illnesses.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Pet Cancer Therapeutics Market Size in 2022: | USD 369 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10% |
2032 Value Projection: | USD 1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 140 |
Tables, Charts & Figures: | 241 |
Segments covered: | Therapy, Route of Administration, Species, Application, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|